Wednesday, April 24, 2024 4/24/2024

RNA post-transcriptional modifications as possible communication hubs between substances of abuse and HIV-1 replication processes

Award Number: R01DA046113
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

Drug abuse represents an aggravating factor in the treatment of HIV/AIDS, which is associated with higher viral load, faster disease progression, and enhanced transmission. Understanding the mechanisms of these potentiating effects at the molecular level could lead to significant changes in the administration of current anti-retroviral treatments and the discovery of new therapeutic targets. Recent findings on the activity of N6-methyladenosine (m6A) in HIV-1 replication and its accumulation in cocaine- treated cells suggest that RNA post-transcriptional modification (PTM) may represent a key component of extensive communications between drug and RNA processes. In addition to m6A, the implementation of a comprehensive analytical approach based on mass spectrometry (MS) allowed us to identify numerous other PTMs on viral RNA isolated from infected cells and virions. Their striking diversity and abundance support the proposal’s hypothesis that RNA PTMs may mediate virus-host communications by modulating essential molecular interactions, which can be influenced by neuromodulators intracellular signaling. Our highly innovative approach will allow us to test this hypothesis by identifying RNA processes that are directly affected by the presence of PTMs, determining the effects of dopamine and GABA signal transduction on PTM expression, and finally recognizing overlaps between the respective pathways, which will reveal possible crosstalk mechanisms between intracellular signaling and viral infection. To this effect, we will perform silencing of PTM enzymes and key regulatory genes to retrace their control networks, while simultaneously monitoring the PTM landscape and essential indicators of virus and cell fitness. We will determine the variations of PTM landscapes in the absence and presence of dopamine and GABA, while simultaneously monitoring the effects on prominent RNA processing infrastructure. We will then probe the PTMs that displayed the most significant variations during both infection and neuromodulator treatment. The fact that the HIV-1 genome does not code for any known biogenetic enzyme implies that host enzymes must be responsible for the detected viral PTMs, thus placing them under the control of key intracellular signaling. Modification may represent adaptation to the host’s metabolic infrastructure, which enables the viral RNA to evade surveillance and elimination by the host’s defenses. Therefore, it is possible to envision that this putative adaptation mechanism could be affected by neuromodulator signaling pathways. This project will look for evidence and will establish the framework necessary to guide in-depth mechanistic investigations. The transformative impact of the proposed activities will be substantiated by the ability to test this hypothesis in comprehensive fashion, expose the influence of PTMs on prominent RNA processes, identify their possible regulatory mechanisms, and understand the significance of their biogenetic enzymes in viral lifecycle and fitness.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2022	UNIVERSITY OF CONNECTICUT	438 WHITNEY RD EXTENSION UNIT 1133	STORRS	CT	06269	TOLLAND	USA	Drug Abuse and Addiction Research Programs	000	5	3/8/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2020	UNIVERSITY OF CONNECTICUT	438 WHITNEY RD EXTENSION UNIT 1133	STORRS	CT	06269	TOLLAND	USA	Drug Abuse and Addiction Research Programs	002	3	2/28/2023	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$614,773
2023	2019	RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE	1400 WASHINGTON AVE	ALBANY	NY	12222	ALBANY	USA	Drug Abuse and Addiction Research Programs	001	2	2/28/2023	NON-COMPETING CONTINUATION	-$373,557
2023	2018	RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE	1400 WASHINGTON AVE	ALBANY	NY	12222	ALBANY	USA	Drug Abuse and Addiction Research Programs	000	1	2/28/2023	NEW	-$241,216
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $389,762 )
2022	2022	UNIVERSITY OF CONNECTICUT	438 WHITNEY RD EXTENSION UNIT 1133	STORRS	CT	06269	TOLLAND	USA	Drug Abuse and Addiction Research Programs	000	5	1/31/2022	NON-COMPETING CONTINUATION	$350,786
2022	2022	UNIVERSITY OF CONNECTICUT	438 WHITNEY RD EXTENSION UNIT 1133	STORRS	CT	06269	TOLLAND	USA	Drug Abuse and Addiction Research Programs	001	5	3/25/2022	NON-COMPETING CONTINUATION	$38,976
														Subtotal = $389,762

Issue Date FY: 2021 ( Subtotal = $389,762 )
2021	2021	UNIVERSITY OF CONNECTICUT	438 WHITNEY RD EXTENSION UNIT 1133	STORRS	CT	06269	TOLLAND	USA	Drug Abuse and Addiction Research Programs	000	4	2/8/2021	NON-COMPETING CONTINUATION	$389,762
														Subtotal = $389,762

Issue Date FY: 2020 ( Subtotal = $389,762 )
2020	2020	UNIVERSITY OF CONNECTICUT	438 WHITNEY RD EXTENSION UNIT 1133	STORRS	CT	06269	TOLLAND	USA	Drug Abuse and Addiction Research Programs	001	3	6/19/2020	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$389,762
2020	2019	RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE	1400 WASHINGTON AVE	ALBANY	NY	12222	ALBANY	USA	Drug Abuse and Addiction Research Programs	000	2	6/19/2020	NON-COMPETING CONTINUATION	$0
														Subtotal = $389,762

Issue Date FY: 2019 ( Subtotal = $373,557 )
2019	2019	RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE	1400 WASHINGTON AVE	ALBANY	NY	12222	ALBANY	USA	Drug Abuse and Addiction Research Programs	000	2	1/28/2019	NON-COMPETING CONTINUATION	$373,557
														Subtotal = $373,557

Issue Date FY: 2018 ( Subtotal = $375,573 )
2018	2018	RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, THE	1400 WASHINGTON AVE	ALBANY	NY	12222	ALBANY	USA	Drug Abuse and Addiction Research Programs	000	1	3/29/2018	NEW	$375,573
														Subtotal = $375,573

Grand Total All Awards = $1,918,416

Top

All Categories

About

Search

Reports

Data Submission

Award Information

RNA post-transcriptional modifications as possible communication hubs between substances of abuse and HIV-1 replication processes

Award Number: R01DA046113

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer